Pharmacological approaches and strategies for therapeutic modulation of fibrinogen

被引:18
作者
Handley, DA
Hughes, TE
机构
[1] Sepracor Inc., Marlborough, MA 01752
[2] Metab. and Cardiovasc. Dis. Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07963
关键词
fibrinogen; fibrin; inflammation; IL-6; fibrates; thrombosis;
D O I
10.1016/S0049-3848(97)00091-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 36
页数:36
相关论文
共 243 条
[31]  
BRANCHI A, 1993, THROMB HAEMOSTASIS, V70, P241
[32]  
Broijersen A, 1996, THROMB HAEMOSTASIS, V76, P171
[33]   THE EFFECTS OF CLOFIBRATE ON PLASMA-GLUCOSE, LIPOPROTEINS, FIBRINOGEN, AND OTHER BIOCHEMICAL AND HEMATOLOGICAL VARIABLES IN PATIENTS WITH MATURE ONSET DIABETES-MELLITUS [J].
CALVERT, GD ;
BLIGHT, L ;
FRANKLIN, J ;
OLIVER, J ;
WISE, P ;
GALLUS, AS .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (05) :355-362
[34]  
CAPPELLI R, 1987, CLIN HEMORHEOL, V7, P247
[35]  
CARLSON LA, 1972, ATHEROSCLEROSIS, V3, P349
[36]   SUSTAINED CORRECTION OF THE BLEEDING-TIME IN AN AFIBRINOGENEMIC PATIENT AFTER INFUSION OF FRESH-FROZEN PLASMA [J].
CATTANEO, M ;
BETTEGA, D ;
LOMBARDI, R ;
LECCHI, A ;
MANNUCCI, PM .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :388-390
[37]   WHOLE-BODY PROTEIN-TURNOVER AND HEPATIC PROTEIN-SYNTHESIS ARE INCREASED BY VACCINATION IN MAN [J].
CAYOL, M ;
TAUVERON, I ;
RAMBOURDIN, F ;
PRUGNAUD, J ;
GACHON, P ;
THIEBLOT, P ;
GRIZARD, J ;
OBLED, C .
CLINICAL SCIENCE, 1995, 89 (04) :389-396
[38]   FIBRINOGEN PLASMA-LEVELS AS A MARKER OF THROMBIN ACTIVATION IN DIABETES [J].
CERIELLO, A ;
TABOGA, C ;
GIACOMELLO, R ;
FALLETI, E ;
DESTASIO, G ;
MOTZ, E ;
LIZZIO, S ;
GONANO, F ;
BARTOLI, E .
DIABETES, 1994, 43 (03) :430-432
[39]   COMPARISON OF ANTITHROMBOTIC ACTION OF THROMBIN-LIKE FRACTION OF MALAYAN PIT VIPER VENOM AND HEPARIN [J].
CHAN, KE .
CARDIOVASCULAR RESEARCH, 1969, 3 (02) :171-+
[40]  
COHEN S, 1953, S Afr J Med Sci, V18, P85